Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,133 | -5,449 | -4,086 | -43 | 0 |
| Accounts payable and accrued liabilities | 459 | 112 | 89 | N/A | N/A |
| Other Working Capital | 519 | 119 | -67 | 43 | 0 |
| Other Operating Activity | 3,273 | 3,517 | 3,455 | 0 | 0 |
| Operating Cash Flow | $-4,882 | $-1,701 | $-609 | $N/A | $0 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | 1 | 1 | N/A | N/A |
| Other Financing Activity | 26,715 | 26,714 | 26,714 | 0 | 0 |
| Financing Cash Flow | $26,716 | $26,715 | $26,715 | $N/A | $0 |
| End Cash Position | 21,834 | 25,014 | 26,106 | N/A | 0 |
| Net Cash Flow | $21,834 | $25,014 | $26,106 | $N/A | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,882 | -1,701 | -609 | N/A | 0 |
| Free Cash Flow | -4,882 | -1,701 | -609 | 0 | 0 |